コンテンツへスキップ
Merck
  • Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.

Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.

The journal of physical chemistry. B (2014-07-31)
Niraj S Trasi, Jared A Baird, Umesh S Kestur, Lynne S Taylor
要旨

Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly important. The goal of this study was to better understand the factors that influence crystal growth rates from pharmaceutically relevant undercooled liquids and to evaluate the range of growth rates observed. The crystal growth rates of 31 drugs were determined using an optical microscope in the temperature region between the glass transition temperature (Tg) and the melting temperature (Tm). Thermodynamic parameters such as Tm, melting enthalpy, and Tg were determined using a differential scanning calorimeter (DSC). Selected viscosity values for the undercooled liquid were taken from the literature. The growth rates of the different compounds were found to be very different from each other with a variation of about 5 orders of magnitude between the fastest growing compounds and the slowest growing compounds. A comparison of the physicochemical properties showed that compounds that had fast crystal growth rates had smaller molecular weights, higher melting temperatures, lower melt entropies, lower melt viscosities, and higher crystal densities. Variations in the growth rates of the compounds could be rationalized to a large extent by considering the thermodynamic driving force for crystallization, the viscosity, and the entropy difference between the melt and undercooled liquid. This study therefore provides important insight into factors that may compromise the stability of amorphous pharmaceuticals.

材料
製品番号
ブランド
製品内容

Supelco
アセトアミノフェン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
アセトアミノフェン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
アセトアミノフェン, BioXtra, ≥99.0%
Sigma-Aldrich
カルバマゼピン, powder
Sigma-Aldrich
アセトアミノフェン, meets USP testing specifications, 98.0-102.0%, powder
Sigma-Aldrich
アセトアミノフェン, analytical standard
Sigma-Aldrich
ケトプロフェン, ≥98% (TLC)
Sigma-Aldrich
クロトリマゾール
Sigma-Aldrich
クロザピン
パラセタモール, European Pharmacopoeia (EP) Reference Standard
Supelco
クロトリマゾール, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ワルファリン, PESTANAL®, analytical standard
Supelco
ケトプロフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
カルバマゼピン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Acetaminophen solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
ワルファリン, analytical standard
Sigma-Aldrich
ピロキシカム, ≥98% (TLC)
Supelco
トルブタミド, analytical standard
Sigma-Aldrich
グリセオフルビン, from Penicillium griseofulvum, 97.0-102.0%
Sigma-Aldrich
ニメスリド
Sigma-Aldrich
ピモジド
USP
クロトリマゾール, United States Pharmacopeia (USP) Reference Standard
USP
ワルファリン, United States Pharmacopeia (USP) Reference Standard
Supelco
カルバマゼピン, analytical standard
Sigma-Aldrich
ドロペリドール
USP
カルバマゼピン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
シンナリジン, powder
Supelco
フルルビプロフェン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ニメスリド, Pharmaceutical Secondary Standard; Certified Reference Material
USP
ケトプロフェン, United States Pharmacopeia (USP) Reference Standard